Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

HOTEZ, PETER

One or more keywords matched the following items that are connected to HOTEZ, PETER

Item Type	Name
Academic Article	Trypanosoma congolense: surface glycoproteins of two early bloodstream variants. I. Production of a relapsing infection in rodents.
Academic Article	Trypanosoma congolense: surface glycoproteins of two early bloodstream variants. II. Purification and partial chemical characterization.
Academic Article	Antigenic variation and the surface glycoproteins of Trypanosoma congolense.
Academic Article	Trypanosoma congolense: surface glycoproteins of two early bloodstream variants. III. Immunochemical characterization.
Academic Article	Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome.
Concept	Membrane Glycoproteins
Concept	Variant Surface Glycoproteins, Trypanosoma
Concept	Glycoproteins
Academic Article	Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.
Academic Article	Limited antigenic variation in the Trypanosoma cruzi candidate vaccine antigen TSA-1.
Academic Article	Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate.
Academic Article	Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice.
Concept	Spike Glycoprotein, Coronavirus
Academic Article	Developing a low-cost and accessible COVID-19 vaccine for global health.
Academic Article	Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
Academic Article	Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate.
Academic Article	SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.
Academic Article	Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1.
Academic Article	A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.
Academic Article	Myocarditis With COVID-19 mRNA Vaccines.
Academic Article	Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate.
Academic Article	An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.
Academic Article	Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.
Academic Article	From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access.

Search Criteria

Glycoproteins